The Vagus Nerve, Autonomic Balance, and the Anti-Inflammatory Reflex — J.P. Hemp Company



Archival anatomical plate — vagus nerve pathway from brainstem to visceral organs with anti-inflammatory reflex in 19th-century engraving style
Vagus nerve pathway reference plate

For most of the twentieth century, the nervous system and the immune system were understood to communicate primarily through the HPA axis — the hormonal pathway that releases cortisol in response to stress. In 2000, a surgeon and neuroscientist named Kevin Tracey discovered a second, faster route: a direct neural pathway through the vagus nerve capable of suppressing inflammation within minutes, without hormones, through an acetylcholine-based reflex. The implications for how psychological and emotional states affect inflammation have not fully settled.

The Autonomic Nervous System — Two Branches, One Balance

The autonomic nervous system governs the body's involuntary functions — heart rate, digestion, respiration, vascular tone — through two opposing branches that work in continuous dynamic tension. The sympathetic branch activates the body for action: it elevates heart rate, dilates the pupils, mobilizes glucose, suppresses digestion, and prepares the musculoskeletal system for effort. The parasympathetic branch supports rest and recovery: it slows the heart, promotes digestion, reduces vascular resistance, and facilitates the restorative functions the body performs when it is not under immediate threat.

Neither branch is better. The system requires both, working in appropriate proportion to the situation. What chronic stress disrupts is that proportion — sustained sympathetic activation at the expense of parasympathetic recovery creates the autonomic imbalance that underlies several of the allostatic load biomarkers described in the preceding article in this pillar. Reduced heart rate variability, elevated resting heart rate, impaired vagal tone — these are measurable consequences of chronically sympathetically dominant autonomic function.

The Vagus Nerve — Architecture and Function

The vagus nerve — cranial nerve X — is the primary carrier of the parasympathetic branch. It runs from the brainstem through the neck and chest into the abdomen, innervating the heart, lungs, esophagus, stomach, small intestine, liver, spleen, kidneys, and colon. It is the longest cranial nerve in the body by considerable distance, and it carries information in both directions: approximately 80–90% of its fibers are afferent — carrying sensory information from the viscera to the brain — and only 10–20% are efferent, carrying motor instructions from the brain to the body.

This predominantly afferent architecture is relevant to the gut-brain axis covered in the Gut Health pillar — the vagus nerve is the primary anatomical route through which gut-derived signals reach the brain. It is also relevant to the cholinergic anti-inflammatory pathway, where efferent vagal fibers produce the inflammatory suppression Tracey's research identified.

The Cholinergic Anti-Inflammatory Pathway

Tracey and colleagues discovered that electrical stimulation of the vagus nerve in animal models of systemic inflammation produced rapid, significant suppression of circulating TNF-α — one of the primary pro-inflammatory cytokines — through a mechanism that did not depend on cortisol, did not require circulating immune cells to travel to the site, and operated within minutes rather than the hours required by hormonal immune modulation.

The mechanism was identified as cholinergic. Efferent vagal fibers release acetylcholine in the spleen and other lymphoid organs. Splenic macrophages express α7 nicotinic acetylcholine receptors. When these receptors are activated by vagally released acetylcholine, macrophage TNF-α production is suppressed — rapidly and substantially. This pathway operates as a physiological brake on systemic inflammatory activity, governed by the autonomic nervous system's balance between sympathetic activation and parasympathetic recovery.

The Cholinergic Anti-Inflammatory Pathway — Step by Step
Step
What Happens
1. Inflammatory signal detected
Afferent vagal fibers detect pro-inflammatory cytokines in the viscera and transmit signals to the brainstem nucleus tractus solitarius — the primary relay station for vagal afferent input. The brain becomes aware of peripheral inflammatory activity through this route.
2. Brainstem anti-inflammatory output
In response, efferent signals travel from the brainstem through the vagus nerve to the celiac ganglion and then to the spleen via the splenic nerve. This efferent signal carries the anti-inflammatory instruction.
3. Acetylcholine release in spleen
Splenic nerve terminals release acetylcholine, which acts on α7 nicotinic receptors expressed on resident splenic macrophages. This is the critical mechanistic step — the neural signal becomes a pharmacological one at the macrophage surface.
4. TNF-α suppression
α7 receptor activation in macrophages suppresses NF-κB signaling and reduces pro-inflammatory cytokine production — primarily TNF-α, but also IL-1β and IL-6. The inflammatory response is attenuated without eliminating immune function — the reflex modulates magnitude, not presence.
5. Tone determines baseline
The efficiency of this reflex is determined by resting vagal tone — individuals with higher vagal tone show more robust anti-inflammatory responses through this pathway. Vagal tone is reduced by chronic stress, sympathetic dominance, social isolation, and poor sleep — the same variables that elevate inflammatory markers in the allostatic load literature.

Heart Rate Variability — The Measurable Proxy

Vagal tone cannot be measured directly in clinical or research settings without invasive procedures. Heart rate variability — HRV — has emerged as the most validated non-invasive proxy. HRV measures the beat-to-beat variation in the interval between heartbeats: a healthy heart does not beat with mechanical regularity but varies its timing continuously in response to respiratory cycles, autonomic input, and physiological demands. Higher variability reflects more flexible, responsive autonomic regulation — a sign of strong parasympathetic influence and good vagal tone. Reduced HRV reflects sympathetic dominance and reduced parasympathetic flexibility — the autonomic signature of chronic stress.

HRV has demonstrated robust associations with all-cause mortality, cardiovascular disease risk, and systemic inflammation in prospective studies. It is one of the biomarkers in the allostatic load panel described in the preceding article. Its practical utility is growing — consumer wearables now track HRV, making it accessible as a personal health metric in a way that cortisol or IL-6 measurement is not.

Polyvagal Theory — Useful Framework, Contested Details

Stephen Porges' polyvagal theory extends the two-branch autonomic model into a three-level hierarchy, proposing that the vagus nerve has two distinct components — a more ancient "dorsal vagal" system associated with immobilization and shutdown responses, and a more recently evolved "ventral vagal" system associated with social engagement, connection, and co-regulation. The theory has been influential in clinical psychology and trauma treatment because it provides a neurobiological framework for understanding how social connection affects physiological state.

The mechanistic details of polyvagal theory are contested in the neuroscience literature — some of its anatomical claims have been challenged and not all aspects have been confirmed. This archive presents the core vagal anti-inflammatory mechanism — which is well-established — and notes the polyvagal framework as context. Readers interested in the social engagement aspects of vagal theory should treat it as a useful orienting framework rather than settled mechanistic fact.

The Endocannabinoid System and Vagal Function

CB1 receptors are expressed on vagal afferent neurons — the fibers carrying sensory information from the gut and viscera to the brainstem. This expression is the mechanistic basis for the endocannabinoid system's role in the gut-brain axis covered in the Gut Health pillar, and it is directly relevant here: CB1 activation on vagal afferents modulates the sensitivity and tone of vagal afferent signaling. Endocannabinoid activity at these receptors influences the information the brain receives from the gut and the strength of the reflex circuits that operate through the vagal pathway.

CBG's Alpha-2 adrenoceptor agonism — its most pharmacologically distinctive mechanism — is relevant to autonomic balance through a different route. Alpha-2 adrenoceptors in the locus coeruleus reduce norepinephrine release from sympathetic neurons when activated, decreasing sympathetic nervous system outflow. Lower sympathetic tone means higher relative parasympathetic tone — and higher parasympathetic tone supports vagal activity, HRV, and the cholinergic anti-inflammatory reflex. The connection is indirect but mechanistically coherent: CBG's noradrenergic mechanism shifts the sympathetic-parasympathetic balance in a direction that supports vagal anti-inflammatory function. Whether this shift is of sufficient magnitude at oral hemp doses to produce measurable HRV changes has not been studied in humans.

The Honest Evidence Summary

The cholinergic anti-inflammatory pathway — the reflex by which vagal efferent activity directly suppresses macrophage TNF-α production via α7 nicotinic receptor activation — is well-established in animal and human models. HRV is a validated non-invasive proxy for vagal tone with documented associations with inflammatory markers and cardiovascular outcomes. Vagal tone is reduced by chronic stress and social isolation, and is associated with the allostatic load biomarker profile.

CB1 receptors on vagal afferents are documented in preclinical research. CBG's Alpha-2 mechanism supports relative parasympathetic tone through sympathetic downregulation. Neither connection has been studied in terms of HRV or cholinergic anti-inflammatory reflex activity as a measured outcome in humans. These are mechanistically coherent Tier 2 connections — the biology is documented; the human clinical evidence has not been generated.

References

  1. Borovikova, L.V., Ivanova, S., Zhang, M., et al. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 405(6785), 458–462.
  2. Cascio, M.G., Gauson, L.A., Stevenson, L.A., et al. (2010). Evidence that the plant cannabinoid cannabigerol is a highly potent alpha-2-adrenoceptor agonist. British Journal of Pharmacology, 159(1), 129–141.
  3. Porges, S.W. (2001). The polyvagal theory: Phylogenetic substrates of a social nervous system. International Journal of Psychophysiology, 42(2), 123–146.
  4. Reardon, C., Murray, K., & Lomax, A.E. (2018). Neuroimmunological regulation of systemic inflammation by the enteric nervous system and vagus nerve. Journal of Immunology, 201(6), 1605–1611.
  5. Thayer, J.F., & Lane, R.D. (2007). The role of vagal function in the risk for cardiovascular disease and mortality. Biological Psychology, 74(2), 224–242.
  6. Tracey, K.J. (2002). The inflammatory reflex. Nature, 420(6917), 853–859.
  7. Zimmer, A., Zimmer, A.M., Hohmann, A.G., et al. (1999). Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proceedings of the National Academy of Sciences, 96(10), 5780–5785.

These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.